The pathophysiology of schizophrenic shows the dysfunction of Glutamate receptors. The inotropic subtypes The NMDA, AMPA and kinate receptors out of various glutamate receptors are most commonly associated. In postmortem brain samples from schizophrenics and controls several levels of gene expression of glutamate receptors were studied. Even though there exist slight inconsistency from various studies certain points. There is an abnormal reduction in the AMPA receptor expression in the schizophrenic hippocampus, including reduced subunit transcript level, protein level and also binding sites. In hippocampus related changes are also seen in the kinate receptor expression. In some cortical regions in schizophrenia NMDAR1 shows abnormal expression. NMDDAR1 is the obligate NMDA receptor subunit. The current review ellustrates the theory of glutamate neurotransmission abnormality in schizophrenia.

The aim of the present study was to determine the antimicrobial property of the solvent extracts of flowers and aerial parts of S. indicus. Methods: The flowers and the aerial parts of Sphaeranthus indicus were extracted with n-hexane, benzene, chloroform, ethyl acetate and acetone respectively. The extracts were analyzed for the antimicrobial effect by disc diffusion method at concentrations of 5, 2.5 and 1.25 mg/disc. The Minimum Inhibitory Concentration (MIC) was tested using broth micro dilution method at concentrations ranging from 5 to 0.039 mg/ml. Results: There was a significant antibacterial and antifungal activity in hexane extract of flower and aerial parts. The MIC was seen at 0.15 mg/ml against Staphylococcus aureus and the highest MIC (5 mg/ml) was noted for S. epidermidis. The n-hexane extracts of flower and aerial parts showed MIC as 0.15 and 1.25 mg/ml respectively against Candida albicans. Conclusion: Concluding it can be said that the S. indicus flower n-hexane extract showed promising antimicrobial agent.

Herbal supplements are used widely all over the world for prevention, delaying onset, decreasing overall severity, and potential reversal of mental illness. The main aimof the overview is to communicate the latest observations regarding the effectiveness of herbal and nutraceutical supplements in the prevention, treatment, and delaying onset of symptomology related to schizophrenia and other schizoaffective disorders, also to explore their laentrole in the future of psychiatry and related health practices. The supplements and their effectiveness studied in this literature overview are Omega-3 fatty acids, curcumin, folic acid, B 12 , B 6 , Vitamin D, N-acetylcysteine, SAM-e, Bacopa monniera, Ginkgo biloba, iron and glycine.